Sponsorship enquiry

Download the Agenda l Stage 1 Cell and Gene Therapy Manufacturing:

Download the Agenda l Stage 1 Cell and Gene Therapy Manufacturing:

Optimise every facet of your manufacturing strategy by participating at the Cell and Gene Therapy Manufacturing Forum.

Benefits of attending: 

  • Join a curated programme taking you from translation and collaboration to ensuring GMP compliance and optimising scalability - this year’s forum is your one-stop shop for building manufacturing capabilities that are compliant, efficient and commercial
  • Engage in our GMP compliance training day to ensure that your process development optimisation does not come at the cost of process compliance
  • Hear from 18+ industry experts to benchmark your manufacturing practices and take home industry leading solutions
  • Optimise your manufacturing process from end-to-end with topics covering every stage of the manufacturing process
  • Plan for your transition towards manufacturing at scale to ensure that your next therapy is market ready
Click on 'download' to view the full speaker line-up and agenda. 

Presentation: Designing a cost effective supply chain for cell therapy:

Presentation: Designing a cost effective supply chain for cell therapy:

Download this free presentation on how to design a robust and cost-effective ‘off-the-shelf’ supply chain for your cell therapy. With insights from Bone Therapeutics’ PhD Production Associate Director, Anne-Sophie LeBrun, this presentation is designed to ensure that your manufacturing process is as efficient and cost effective as possible

The Bone Therapeutics presentation will give you insights on: 

  • Examining cell therapy as a game changer for orthopaedic indications 
  • Identifying major indications and on-going clinical trials 
  • Evaluating the feasibility of large-scale manufacturing 
  • Understanding the journey from a scientific concept to a commercial concept 
  • Setting the objectives and taking capacity and costs into consideration 
  • Assessing the feasibility of cell expansion and storage
  • Plus more.

Fill in your details to download this free presentation. 


Cell and Gene Therapy: European Heatmap 2019:

Cell and Gene Therapy: European Heatmap 2019:

Back by popular demand, the 2019 industry heatmap provides a high level overview of the latest developments in the European novel therapy manufacturing space across The United Kingdom, Belgium, Greece and Switzerland, among others

With the 2018 commercialisation of prominent Autologous therapies such as KITEs Yskarta and Novartis’ Kymriah in the global market, more and more companies are beginning to move towards commercially based products. Yet despite these unquestionable industry growths, challenging issues can hinder – and even halt – groundbreaking progress in its tracks. There are still no established routes to market and with continuous changes in regulatory requirements across different global markets achieving any form of standardisation is difficult.

Download this free resource to gain valuable insights on some of the biggest challenges:

  • globalising production and commercialisation
  • scalability
  • cost efficiency
  • regulatory pathways
  • supply and logistics

Joining this year’s curated programme will take you through a series of sessions from translation and collaboration to ensuring GMP compliance and optimising scalability. This year’s forum is also your one-stop shop for:

  • Building manufacturing capabilities that are compliant, efficient and commercial
  • Engaging in our GMP compliance training day to ensure that your process development optimisation does not come at the cost of process compliance
  • Hearing from 18+ industry experts to benchmark your manufacturing practices and taking home industry leading solutions
  • Optimising your manufacturing processes from end-to-end with topics covering every stage of the manufacturing process
  • Helping to plan for your transition towards manufacturing at scale to ensure that your next therapy is market ready
  • Gaining a practical understanding of data integrity issues and how it relates to manufacturing
  • Exploring how to best identify, reduce and prevent potential data integrity breaches

To find out more information on the sessions, download the full agenda of the conference here. To request a copy to be sent via email, please click here.

Cell and Gene Therapy Manufacturing Programme

Optimise every facet of your manufacturing strategy by participating at the Cell and Gene Therapy Manufacturing Forum.

Benefits of attending: 

  • Join a curated programme taking you from translation and collaboration to ensuring GMP compliance and optimising scalability - this year’s forum is your one-stop shop for building manufacturing capabilities that are compliant, efficient and commercial
  • Engage in our GMP compliance training day to ensure that your process development optimisation does not come at the cost of process compliance
  • Hear from 18+ industry experts to benchmark your manufacturing practices and take home industry leading solutions
  • Optimise your manufacturing process from end-to-end with topics covering every stage of the manufacturing process
  • Plan for your transition towards manufacturing at scale to ensure that your next therapy is market ready
Click on 'download' to view the full speaker line-up and agenda. 

Cell and Gene Digital Prospectus

Webinar 7-8 July

Sponsoring Cell and Gene Therapy Development Online is a unique opportunity to align your company’s offering to match the needs of key prospects, at a time when they are pivoting their process development and manufacturing strategies to drive clinical development and sustain regulatory compliance for cell and gene therapies under Covid-19 and beyond.

View the webinar prospectus by submitting the form to the right >

Who will attend?

  • Chief Operating Officers
  • Chief Executive Officers
  • Heads of Process Development
  • Heads of Innovation Technologies
  • Process Scientists
  • Heads of GMP Manufacturing
  • Heads of Production
  • Heads of Quality Assurance of Regulatory Compliance